Please login to the form below

Not currently logged in
Email:
Password:

Farxiga

This page shows the latest Farxiga news and features for those working in and with pharma, biotech and healthcare.

Boehringer/Lilly's Jardiance hits the mark in pivotal heart failure trial

Boehringer/Lilly's Jardiance hits the mark in pivotal heart failure trial

This includes AstraZeneca’s Farxiga (dapagliflozin), which became the first drug in the SGLT2 inhibitor class to be approved in the US to reduce the chance of hospitalisations, in adults with ... Earlier this week, AZ also touted results for Farxiga in

Latest news

More from news
Approximately 12 fully matching, plus 39 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Windrose Consulting Group

Windrose Consulting Group helps life science companies maximize the commercial value of their products and bring new innovations to market...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
...
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics